MPM Capital
North America, Massachusetts, United States, Boston
Description
MPM Capital is a biotechnology investment firm that invests in companies to develop therapeutic technologies in oncology.
Investor Profile
MPM Capital has made 291 investments, with 3 in the past 12 months and 31% as lead.
Stage Focus
- Series B (26%)
- Series A (25%)
- Series C (19%)
- Series Unknown (10%)
- Series D (8%)
- Series E (3%)
- Seed (3%)
- Post Ipo Equity (2%)
- Private Equity (2%)
Country Focus
- United States (92%)
- Canada (2%)
- United Kingdom (1%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Italy (1%)
- Germany (1%)
- Taiwan (1%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(60)'/%3e%3ccircle r='17' fill='%23000095'/%3e%3ccircle r='15' fill='%23fff'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Medical
- Biopharma
- Medical Device
- Health Diagnostics
- Life Science
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
